Unlike other industries, where artificial intelligence has successfully replaced many human interactions, healthcare must remain human first, technology second. Source link
More than 150 people – including biotechnology and investment executives and academics – have signed a letter warning that actions against Chinese scientists threaten U.S. leadership in biomedical science. Source link
The company, which makes women’s health drugs, said in an email that it had resolved the issue. The charges relate to alleged disclosures of nonpublic information to investment analysts in 2017 concerning interactions with the FDA. Source link
The partnership builds on an existing relationship between All of Us and Color, which was chosen as one of three genome centers that are responsible for actual genotyping of patient samples. Source link
While the devices themselves will be free for users, additional health coaching services and software offerings will require a monthly fee. Source link
Cigna’s sharpened focus on healthcare is evidenced by a number of recent moves, including, most notably its $54 billion acquisition of pharmacy benefits manager Express Scripts last year.  Source link
The company said Wednesday that the pairing of PD-L1 inhibitor Imfinzi and CTLA-4 inhibitor tremelimumab did not prolong overall survival in previously untreated metastatic non-small cell lung cancer. The Phase III results are the latest in a string of failures for the combination. Source link
Several FDA approvals have attracted controversy and a perception of lowered standards at the agency. However, others see the current regulatory regime as a net positive and part of an institutional tension between patient protection and speedy approval of badly needed therapies. Source link
The health plan hopes to better address the needs of underserved populations through community-based teams that can understand and overcome social barriers to care. Source link
In a note to investors, SVB Leerink analyst Joseph Schwartz suggested that the ‘questionable’ approval of Sarepta’s Exondys 51 may have played a role in the FDA’s decision to turn down golodirsen. Source link

Latest Posts